Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up

ATASEVEN, Hüseyin; REİSLİ, İsmail; CALISKANER, Ahmet Zafer; UÇAR, Ramazan; SELÇUK, Nedim Yılmaz; ARSLAN, Şevket

Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up

Ahmet Zafer ÇALIŞKANER, (Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Konya, Türkiye)

İsmail REİSLİ, (Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Çocuk Allerji ve Klinik İmmünoloji Anabilim Dalı, Konya, Türkiye)

Şevket ARSLAN, (Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Konya, Türkiye)

Ramazan UÇAR, (Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Alerji ve Klinik İmmünoloji Anabilim Dalı, Konya, Türkiye)

Hüseyin ATASEVEN, (Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi, Gastroenteroloji Bölümü, Konya, Türkiye)

Nedim Yılmaz SELÇUK (Meram Tıp Fakültesi Nöroloji Anabilim Dalı, Necmettin Erbakan Üniversitesi, Konya, Türkiye)

Turkish Journal of Medical Sciences

0 0

Yıl: 2016 Cilt: 46 Sayı: 2 Sayfa Aralığı: 430 - 436 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up

Öz:

Background/aim: The aim of this study is to establish follow-up protocols for adult patients with common variable immunodeficiency (CVID) in a recently founded adult immunology clinic in the Central Anatolia Region of Turkey, where a clinical immunology center for adults was not available previously. Materials and methods: A total of 25 patients with CVID aged 18 years and older were included in this study. The file format consisted of 13 pages and was developed for the purpose of the study. Separate sections were designated for identity information, medical history, disease course, previous and current laboratory and imaging studies, follow-up plans, detection and management of complications/ comorbidities, and treatment results. Results: The mean age of the patients was 36.6 ± 13.4 years. The delay in diagnosis was 107 ± 95.6 months. In 92% of patients, initial symptoms resulting in admission to healthcare facilities were infections. Seventeen of 25 patients (68%) had bronchiectasis at the beginning of follow-up. Conclusion: Early identification of complications and comorbidities in patients with CVID will significantly improve quality of life and survival. Close observation and standardized protocols for follow-up are essential components of management.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Yong PF, Thaventhiran JE, Grimbacher B. A rose is a rose is a rose, but CVID is not CVID: Common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol 2011; 111: 47107.
2. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116: 715.
3. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012; 119: 16501657.
4. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, Claudio P, Franco D, Pesce AM, Borghese F et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007; 27: 308316.
5. Shehata N, Palda V, Bowen T, Haddad E, Issekutz TB, Mazer B, Schellenberg R, Warrington R, Easton D, Anderson D et al. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Transfus Med Rev 2010; 24: 2850.
6. Detková D, Español T. An update on treatment strategies for common variable immunodeficiency. Exp Rev Clin Immunol 2009; 5: 381390.
7. Kumar Y, Bhatia A. Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures. Exp Rev Clin Immunol 2013; 9: 959977.
8. García JM, Gamboa P, de la Calle A, Hernández MD, Caballero MT, García BE, Labrador M, Lahoz C, Longo Areso N, López Hoyos M et al. Diagnosis and management of immunodeficiencies in adults by allergologists. J Invest Allerg Clin 2010; 20: 185194.
9. Ardeniz O, Başoğlu OK, Günşar F, Unsel M, Bayraktaroğlu S, Mete N, Gülbahar O, Sin A. Clinical and immunological analysis of 23 adult patients with common variable immunodeficiency. J Invest Allerg Clin 2010; 20: 222236.
10. Maarschalk-Ellerbroek LJ, Hoepelman AI, van Montfrans JM, Ellerbroek PM. The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital. J Clin Immunol 2012; 32: 907921.
11. Ballow M. Managing comorbid complications in patients with common variable immunodeficiency. Ann Allerg Asthma Im 2013; 111: 69.
12. Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J Allergy Clin Immun 2013; 1: 545556.
13. Podjasek JC, Abraham RS. Autoimmune cytopenias in common variable immunodeficiency. Front Immunol 2012; 24: 189.
14. Abolhassani H, Amirkashani D, Parvaneh N, Mohammadinejad P, Gharib B, Shahinpour S, Hirbod-Mobarakeh A, Mirghorbani M, Movahedi M, Gharagozlou M et al. Autoimmune phenotype in patients with common variable immunodeficiency. J Invest Allerg Clin 2013; 23: 323329.
15. Agarwal S, Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis 2010; 16: 703711.
16. Daniels JA, Lederman HM, Maitra A, Montgomery EA. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol 2007; 31: 18001812.
17. Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011; 165: 17.
18. Aghamohammadi A, Moin M, Kouhi A, Mohagheghi MA, Shirazi A, Rezaei N, Tavassoli S, Esfahani M, Cheraghi T, Dastan J et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology 2008; 213: 447454.
19. Serra G, Milito C, Mitrevski M, Granata G, Martini H, Pesce AM, Sfika I, Bonanni L, Catalano C, Fraioli F et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest 2011; 140: 15811589.

APA	CALISKANER A, REİSLİ İ, ARSLAN Ş, UÇAR R, ATASEVEN H, SELÇUK N (2016). Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. , 430 - 436.
Chicago	CALISKANER Ahmet Zafer,REİSLİ İsmail,ARSLAN Şevket,UÇAR Ramazan,ATASEVEN Hüseyin,SELÇUK Nedim Yılmaz Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. (2016): 430 - 436.
MLA	CALISKANER Ahmet Zafer,REİSLİ İsmail,ARSLAN Şevket,UÇAR Ramazan,ATASEVEN Hüseyin,SELÇUK Nedim Yılmaz Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. , 2016, ss.430 - 436.
AMA	CALISKANER A,REİSLİ İ,ARSLAN Ş,UÇAR R,ATASEVEN H,SELÇUK N Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. . 2016; 430 - 436.
Vancouver	CALISKANER A,REİSLİ İ,ARSLAN Ş,UÇAR R,ATASEVEN H,SELÇUK N Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. . 2016; 430 - 436.
IEEE	CALISKANER A,REİSLİ İ,ARSLAN Ş,UÇAR R,ATASEVEN H,SELÇUK N "Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up." , ss.430 - 436, 2016.
ISNAD	CALISKANER, Ahmet Zafer vd. "Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up". (2016), 430-436.

APA	CALISKANER A, REİSLİ İ, ARSLAN Ş, UÇAR R, ATASEVEN H, SELÇUK N (2016). Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. Turkish Journal of Medical Sciences, 46(2), 430 - 436.
Chicago	CALISKANER Ahmet Zafer,REİSLİ İsmail,ARSLAN Şevket,UÇAR Ramazan,ATASEVEN Hüseyin,SELÇUK Nedim Yılmaz Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. Turkish Journal of Medical Sciences 46, no.2 (2016): 430 - 436.
MLA	CALISKANER Ahmet Zafer,REİSLİ İsmail,ARSLAN Şevket,UÇAR Ramazan,ATASEVEN Hüseyin,SELÇUK Nedim Yılmaz Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. Turkish Journal of Medical Sciences, vol.46, no.2, 2016, ss.430 - 436.
AMA	CALISKANER A,REİSLİ İ,ARSLAN Ş,UÇAR R,ATASEVEN H,SELÇUK N Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. Turkish Journal of Medical Sciences. 2016; 46(2): 430 - 436.
Vancouver	CALISKANER A,REİSLİ İ,ARSLAN Ş,UÇAR R,ATASEVEN H,SELÇUK N Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up. Turkish Journal of Medical Sciences. 2016; 46(2): 430 - 436.
IEEE	CALISKANER A,REİSLİ İ,ARSLAN Ş,UÇAR R,ATASEVEN H,SELÇUK N "Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up." Turkish Journal of Medical Sciences, 46, ss.430 - 436, 2016.
ISNAD	CALISKANER, Ahmet Zafer vd. "Common variable immunodeficiency in adults requires reserved protocols for long-term follow-up". Turkish Journal of Medical Sciences 46/2 (2016), 430-436.